HighTower Advisors LLC Raises Stock Position in Healthpeak Properties, Inc. $DOC

Key Points

• HighTower Advisors LLC increased its stake in Healthpeak Properties by 9.3%, owning 192,143 shares valued at approximately $3.89 million.
• Healthpeak Properties has faced recent price target downgrades from various analysts, with Evercore ISI reducing their target from $23 to $21.
• The company declared a dividend of $0.1017 per share, resulting in a yield of 705.0% with a payout ratio of 508.33%.

HighTower Advisors LLC raised its stake in Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 9.3% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 192,143 shares of the real estate investment trust's stock after buying an additional 16,277 shares during the period. HighTower Advisors LLC's holdings in Healthpeak Properties were worth $3,885,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in DOC. Nuveen LLC purchased a new position in Healthpeak Properties in the first quarter valued at about $124,113,000. Resolution Capital Ltd purchased a new position in shares of Healthpeak Properties during the 4th quarter worth approximately $122,795,000. Invesco Ltd. increased its stake in shares of Healthpeak Properties by 20.7% during the 1st quarter. Invesco Ltd. now owns 23,111,320 shares of the real estate investment trust's stock worth $467,311,000 after purchasing an additional 3,967,830 shares in the last quarter. Northern Trust Corp increased its stake in shares of Healthpeak Properties by 32.6% during the 4th quarter. Northern Trust Corp now owns 10,526,223 shares of the real estate investment trust's stock worth $213,367,000 after purchasing an additional 2,590,530 shares in the last quarter. Finally, Centersquare Investment Management LLC increased its stake in shares of Healthpeak Properties by 18.5% during the 1st quarter. Centersquare Investment Management LLC now owns 13,285,932 shares of the real estate investment trust's stock worth $268,642,000 after purchasing an additional 2,070,416 shares in the last quarter. 93.57% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other Healthpeak Properties news, Director Tommy G. Thompson bought 5,777 shares of the business's stock in a transaction dated Wednesday, May 28th. The shares were acquired at an average price of $17.27 per share, with a total value of $99,768.79. Following the purchase, the director owned 144,290 shares in the company, valued at approximately $2,491,888.30. The trade was a 4.17% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Scott M. Brinker bought 2,930 shares of the business's stock in a transaction dated Thursday, July 31st. The stock was acquired at an average cost of $17.06 per share, for a total transaction of $49,985.80. Following the purchase, the chief executive officer owned 210,416 shares in the company, valued at approximately $3,589,696.96. This trade represents a 1.41% increase in their position. The disclosure for this purchase can be found here. In the last three months, insiders bought 14,560 shares of company stock worth $249,898. Insiders own 0.23% of the company's stock.

Healthpeak Properties Trading Down 0.7%

Shares of DOC traded down $0.12 during mid-day trading on Tuesday, reaching $17.54. The company had a trading volume of 9,519,723 shares, compared to its average volume of 7,810,007. The stock has a market cap of $12.19 billion, a price-to-earnings ratio of 73.07, a price-to-earnings-growth ratio of 2.26 and a beta of 1.05. The firm has a fifty day simple moving average of $17.64 and a 200-day simple moving average of $18.34. Healthpeak Properties, Inc. has a fifty-two week low of $16.63 and a fifty-two week high of $23.26. The company has a current ratio of 1.28, a quick ratio of 1.28 and a debt-to-equity ratio of 1.06.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. The company had revenue of $694.35 million for the quarter, compared to analyst estimates of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. Healthpeak Properties's revenue for the quarter was down .2% on a year-over-year basis. During the same quarter last year, the business earned $0.45 EPS. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. On average, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current fiscal year.

Healthpeak Properties Dividend Announcement

The firm also recently announced a dividend, which will be paid on Friday, August 29th. Stockholders of record on Tuesday, August 19th will be paid a $0.1017 dividend. This represents a dividend yield of 705.0%. The ex-dividend date of this dividend is Monday, August 18th. Healthpeak Properties's dividend payout ratio (DPR) is currently 508.33%.

Analyst Ratings Changes

A number of brokerages have recently weighed in on DOC. Morgan Stanley dropped their price objective on shares of Healthpeak Properties from $22.00 to $21.00 and set an "overweight" rating for the company in a research note on Friday. Robert W. Baird set a $21.00 price objective on shares of Healthpeak Properties and gave the stock an "outperform" rating in a research note on Wednesday, July 30th. Wells Fargo & Company dropped their price objective on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research note on Monday, June 2nd. Wedbush decreased their target price on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Monday, April 28th. Finally, Deutsche Bank Aktiengesellschaft restated a "hold" rating and set a $18.00 target price (down previously from $28.00) on shares of Healthpeak Properties in a research report on Wednesday, August 20th. Seven analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $21.70.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.